Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α

Cheryl S. Watson, Andrea M. Norfleet, Todd C. Pappas, Bahiru Gametchu

    Research output: Contribution to journalArticle

    146 Citations (Scopus)

    Abstract

    The focus of our work on rapid actions of estrogens has been on the immuno-identification of a membrane version of the estrogen receptor-α (mERα) and the correlation of the presence of this receptor to the rapid secretion of prolactin in pituitary tumor cells. We demonstrated the mERα by both fluorescence and immuno-enzyme-cytochemistry and with both conventional and confocal microscopy in the cell line GH3/B6 and its sublines. Its presence on cells (including recently subcloned ones) is very heterogenous, unlike the nuclear ERα, which is present in every cell. An impeded ligand (estradiol covalently linked to BSA) binds to mERα and elicits the same response. A total of eight antibodies to ERα recognize mERα, making it likely that the membrane and nuclear proteins are highly related. Immunoidentification techniques have also been used to identify mERα on the MCF-7 human breast cancer cell line. Estradiol at very low concentrations elicits prolactin release from GH3/B6 cells within a few minutes of application. This response is bimodal, with effective concentrations in both the picomolar and nanomolar ranges. Prolactin release is also elicited or inhibited by ERα-specific antibodies. The characteristics of mERα and the membrane receptor for glucocorticoids have many similarities, suggesting that this mode of subcellular location/function alternative might be used by other members of the gene family.

    Original languageEnglish (US)
    Pages (from-to)5-13
    Number of pages9
    JournalSteroids
    Volume64
    Issue number1-2
    DOIs
    StatePublished - Jan 1999

    Fingerprint

    Pituitary Neoplasms
    Cell membranes
    Estrogen Receptors
    Tumors
    Estrogens
    Cells
    Cell Membrane
    Membranes
    Prolactin
    Estradiol
    Cell Line
    Histocytochemistry
    Antibodies
    Confocal microscopy
    Glucocorticoid Receptors
    Nuclear Proteins
    Confocal Microscopy
    Membrane Proteins
    Genes
    Fluorescence

    Keywords

    • Breast cancer
    • Estrogen Membrane steroid receptor
    • Estrogen receptor-α
    • Prolactin release

    ASJC Scopus subject areas

    • Biochemistry
    • Endocrinology
    • Molecular Biology

    Cite this

    Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α. / Watson, Cheryl S.; Norfleet, Andrea M.; Pappas, Todd C.; Gametchu, Bahiru.

    In: Steroids, Vol. 64, No. 1-2, 01.1999, p. 5-13.

    Research output: Contribution to journalArticle

    Watson, Cheryl S. ; Norfleet, Andrea M. ; Pappas, Todd C. ; Gametchu, Bahiru. / Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α. In: Steroids. 1999 ; Vol. 64, No. 1-2. pp. 5-13.
    @article{9ea27a1307234e62a2973500a9df6fcf,
    title = "Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α",
    abstract = "The focus of our work on rapid actions of estrogens has been on the immuno-identification of a membrane version of the estrogen receptor-α (mERα) and the correlation of the presence of this receptor to the rapid secretion of prolactin in pituitary tumor cells. We demonstrated the mERα by both fluorescence and immuno-enzyme-cytochemistry and with both conventional and confocal microscopy in the cell line GH3/B6 and its sublines. Its presence on cells (including recently subcloned ones) is very heterogenous, unlike the nuclear ERα, which is present in every cell. An impeded ligand (estradiol covalently linked to BSA) binds to mERα and elicits the same response. A total of eight antibodies to ERα recognize mERα, making it likely that the membrane and nuclear proteins are highly related. Immunoidentification techniques have also been used to identify mERα on the MCF-7 human breast cancer cell line. Estradiol at very low concentrations elicits prolactin release from GH3/B6 cells within a few minutes of application. This response is bimodal, with effective concentrations in both the picomolar and nanomolar ranges. Prolactin release is also elicited or inhibited by ERα-specific antibodies. The characteristics of mERα and the membrane receptor for glucocorticoids have many similarities, suggesting that this mode of subcellular location/function alternative might be used by other members of the gene family.",
    keywords = "Breast cancer, Estrogen Membrane steroid receptor, Estrogen receptor-α, Prolactin release",
    author = "Watson, {Cheryl S.} and Norfleet, {Andrea M.} and Pappas, {Todd C.} and Bahiru Gametchu",
    year = "1999",
    month = "1",
    doi = "10.1016/S0039-128X(98)00107-X",
    language = "English (US)",
    volume = "64",
    pages = "5--13",
    journal = "Steroids",
    issn = "0039-128X",
    publisher = "Elsevier Inc.",
    number = "1-2",

    }

    TY - JOUR

    T1 - Rapid actions of estrogens in GH3/B6 pituitary tumor cells via a plasma membrane version of estrogen receptor-α

    AU - Watson, Cheryl S.

    AU - Norfleet, Andrea M.

    AU - Pappas, Todd C.

    AU - Gametchu, Bahiru

    PY - 1999/1

    Y1 - 1999/1

    N2 - The focus of our work on rapid actions of estrogens has been on the immuno-identification of a membrane version of the estrogen receptor-α (mERα) and the correlation of the presence of this receptor to the rapid secretion of prolactin in pituitary tumor cells. We demonstrated the mERα by both fluorescence and immuno-enzyme-cytochemistry and with both conventional and confocal microscopy in the cell line GH3/B6 and its sublines. Its presence on cells (including recently subcloned ones) is very heterogenous, unlike the nuclear ERα, which is present in every cell. An impeded ligand (estradiol covalently linked to BSA) binds to mERα and elicits the same response. A total of eight antibodies to ERα recognize mERα, making it likely that the membrane and nuclear proteins are highly related. Immunoidentification techniques have also been used to identify mERα on the MCF-7 human breast cancer cell line. Estradiol at very low concentrations elicits prolactin release from GH3/B6 cells within a few minutes of application. This response is bimodal, with effective concentrations in both the picomolar and nanomolar ranges. Prolactin release is also elicited or inhibited by ERα-specific antibodies. The characteristics of mERα and the membrane receptor for glucocorticoids have many similarities, suggesting that this mode of subcellular location/function alternative might be used by other members of the gene family.

    AB - The focus of our work on rapid actions of estrogens has been on the immuno-identification of a membrane version of the estrogen receptor-α (mERα) and the correlation of the presence of this receptor to the rapid secretion of prolactin in pituitary tumor cells. We demonstrated the mERα by both fluorescence and immuno-enzyme-cytochemistry and with both conventional and confocal microscopy in the cell line GH3/B6 and its sublines. Its presence on cells (including recently subcloned ones) is very heterogenous, unlike the nuclear ERα, which is present in every cell. An impeded ligand (estradiol covalently linked to BSA) binds to mERα and elicits the same response. A total of eight antibodies to ERα recognize mERα, making it likely that the membrane and nuclear proteins are highly related. Immunoidentification techniques have also been used to identify mERα on the MCF-7 human breast cancer cell line. Estradiol at very low concentrations elicits prolactin release from GH3/B6 cells within a few minutes of application. This response is bimodal, with effective concentrations in both the picomolar and nanomolar ranges. Prolactin release is also elicited or inhibited by ERα-specific antibodies. The characteristics of mERα and the membrane receptor for glucocorticoids have many similarities, suggesting that this mode of subcellular location/function alternative might be used by other members of the gene family.

    KW - Breast cancer

    KW - Estrogen Membrane steroid receptor

    KW - Estrogen receptor-α

    KW - Prolactin release

    UR - http://www.scopus.com/inward/record.url?scp=0032929779&partnerID=8YFLogxK

    UR - http://www.scopus.com/inward/citedby.url?scp=0032929779&partnerID=8YFLogxK

    U2 - 10.1016/S0039-128X(98)00107-X

    DO - 10.1016/S0039-128X(98)00107-X

    M3 - Article

    VL - 64

    SP - 5

    EP - 13

    JO - Steroids

    JF - Steroids

    SN - 0039-128X

    IS - 1-2

    ER -